XSHG
600718
Market cap1.29bUSD
Jul 10, Last price
8.00CNY
1D
9.14%
1Q
-11.99%
Jan 2017
-59.31%
Name
Neusoft Corp
Chart & Performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Neusoft Corporation is a global provider specializing in advanced software and information technology services. The company's diverse offerings include: Healthcare solutions: This encompasses systems for hospital administration, cloud-based platforms for medical research, and automated analysis tools for medical data. Automotive technologies: Neusoft develops intelligent cockpit systems, vehicle computing platforms, in-car infotainment features, digital instrument clusters, alongside navigation and connectivity solutions for vehicles. Operational platforms: Its suite of platforms supports critical enterprise functions such as data integration, automated quality assurance testing, data analytics, IT infrastructure monitoring, cloud operations management, enterprise mobility tools, and application performance monitoring. Business applications: The firm provides a variety of enterprise-level applications covering human capital management, archives, financial operations, knowledge management, video surveillance, e-commerce, and supply chain optimization. Smart products: Neusoft's portfolio of intelligent products features service robots, self-service terminals, enterprise-grade terminals, all-in-one service platforms, and robust network security systems. Neusoft serves a wide array of sectors, including healthcare, transportation, intellectual property, smart venues, telecommunications, education, environmental protection, energy, manufacturing, food and drug safety, finance, media, and science and technology. Founded in 1991, the company's corporate headquarters are situated in Shenyang, People's Republic of China.
Valuation
Title CNY in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025‑12 | 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | |
| Income | ||||||||||
Revenues | ||||||||||
Cost of revenue | ||||||||||
Unusual Expense (Income) | ||||||||||
NOPBT | ||||||||||
NOPBT Margin | ||||||||||
Operating Taxes | ||||||||||
Tax Rate | ||||||||||
NOPAT | ||||||||||
Net income | ||||||||||
Dividends | ||||||||||
Dividend yield | ||||||||||
Proceeds from repurchase of equity | ||||||||||
BB yield | ||||||||||
| Debt | ||||||||||
Debt current | ||||||||||
Long-term debt | ||||||||||
Deferred revenue | ||||||||||
Other long-term liabilities | ||||||||||
Net debt | ||||||||||
| Cash flow | ||||||||||
Cash from operating activities | ||||||||||
CAPEX | ||||||||||
Cash from investing activities | ||||||||||
Cash from financing activities | ||||||||||
FCF | ||||||||||
| Balance | ||||||||||
Cash | ||||||||||
Long term investments | ||||||||||
Excess cash | ||||||||||
Stockholders' equity | ||||||||||
Invested Capital | ||||||||||
ROIC | ||||||||||
ROCE | ||||||||||
| EV | ||||||||||
Common stock shares outstanding | ||||||||||
Price | ||||||||||
Market cap | ||||||||||
EV | ||||||||||
EBITDA | ||||||||||
EV/EBITDA | ||||||||||
Interest | ||||||||||
Interest/NOPBT | ||||||||||